CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE
Third quarter total revenues increased to $108.4 billion, up 5.4% year-over-year Third quarter GAAP diluted EPS of $1.68 and Adjusted EPS of $2.09 Generated year-to-date cash flow from operations of $15.3 billion Raising full-year 2026 guidance:GAAP diluted EPS guidance to at least $6.98...
Covered in this story
Call it yourself
No calls on $CVS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on CVS Health →Dalsna Finance is currently tracking 6 stories mentioning CVS Health, the earliest published 9 Sept 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.